Detalhe da pesquisa
1.
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
N Engl J Med;
389(1): 33-44, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37407001
2.
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
Blood;
143(16): 1565-1575, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38252906
3.
Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss.
Annu Rev Med;
74: 279-291, 2023 01 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36332638
4.
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
Br J Haematol;
204(3): 887-891, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38054558
5.
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
Lancet;
402(10402): 641-654, 2023 08 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37295445
6.
Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells.
Mol Ther;
31(3): 676-685, 2023 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36518079
7.
The role of noncovalent BTK inhibitors in the era of covalent BTK inhibitors.
Clin Adv Hematol Oncol;
22(3): 140-147, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38588273
8.
Randomized Placebo-Controlled Trial of 60-Day Percutaneous Peripheral Nerve Stimulation Treatment Indicates Relief of Persistent Postoperative Pain, and Improved Function After Knee Replacement.
Neuromodulation;
2024 May 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38739062
9.
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?
Blood;
137(10): 1416-1423, 2021 03 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33120429
10.
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Blood;
138(22): 2278-2289, 2021 12 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34265047
11.
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
Haematologica;
108(1): 98-109, 2023 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35833303
12.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet;
397(10277): 892-901, 2021 03 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33676628
13.
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.
Blood;
135(20): 1739-1749, 2020 05 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32160294
14.
Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies.
Cytotherapy;
24(8): 767-773, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35597752
15.
Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells.
Am J Hematol;
97(12): 1580-1588, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36068950
16.
BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma.
Future Oncol;
18(36): 3961-3969, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36377973
17.
Rap1A, Rap1B, and ß-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol.
Yale J Biol Med;
95(1): 45-56, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35370486
18.
Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?
Cytotherapy;
23(11): 985-990, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34538575
19.
High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing.
Proc Natl Acad Sci U S A;
115(42): E9944-E9952, 2018 10 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30275336
20.
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
Biol Blood Marrow Transplant;
26(5): 893-901, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31982543